Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuangyan Cao

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Rheumatology|November 17, 2010
ERAP1 is associated with ankylosing spondylitis in Han ChineseChao Li, Zhiming Lin, Yingying Xie, et al.
Rheumatology (Oxford, England)|March 6, 2020
Identification of the urine and serum metabolomics signature of goutYefei Huang, Min Xiao, Jiayong Ou, et al.
Clinical and Experimental Rheumatology|November 18, 2017
Effects and safety of 99Tc-MDP in patients with refractory ankylosing spondylitis: a 2-stage (30-week follow-up) clinical trialYunyun Xu, Yi Zhong, Minjing Zhao, et al.
Biomed Research International|August 15, 2015
Disorders of MicroRNAs in Peripheral Blood Mononuclear Cells: As Novel Biomarkers of Ankylosing Spondylitis and Provocative Therapeutic TargetsQing Lv, Qiuxia Li, Peizhuo Zhang, et al.
Plos One|May 16, 2015
A rare co-segregation-mutation in the insulin receptor substrate 1 gene in one Chinese family with ankylosing spondylitisJu Rong, Qiuxia Li, Pingping Zhang, et al.
International Journal of Rheumatic Diseases|August 18, 2012
Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitisZaiying Hu, Manlong Xu, Qiuxia Li, et al.
Frontiers in Pharmacology|March 27, 2020
Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative StudyJialing Wu, Xinyu Wu, Zena Chen, et al.
Arthritis Research & Therapy|June 21, 2020
TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitisMingcan Yang, Qing Lv, Qiujing Wei, et al.
Clinical and Experimental Rheumatology|September 21, 2013
Limitations of lumbar spine MRI in the diagnosis of ankylosing spondylitisZaiying Hu, Manlong Xu, Zhiming Lin, et al.
Frontiers in Immunology|September 12, 2022
Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trialLiudan Tu, Minjing Zhao, Xiaohong Wang, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Rheumatology|November 17, 2010
ERAP1 is associated with ankylosing spondylitis in Han ChineseChao Li, Zhiming Lin, Yingying Xie, et al.
Rheumatology (Oxford, England)|March 6, 2020
Identification of the urine and serum metabolomics signature of goutYefei Huang, Min Xiao, Jiayong Ou, et al.
Clinical and Experimental Rheumatology|November 18, 2017
Effects and safety of 99Tc-MDP in patients with refractory ankylosing spondylitis: a 2-stage (30-week follow-up) clinical trialYunyun Xu, Yi Zhong, Minjing Zhao, et al.
Biomed Research International|August 15, 2015
Disorders of MicroRNAs in Peripheral Blood Mononuclear Cells: As Novel Biomarkers of Ankylosing Spondylitis and Provocative Therapeutic TargetsQing Lv, Qiuxia Li, Peizhuo Zhang, et al.
Plos One|May 16, 2015
A rare co-segregation-mutation in the insulin receptor substrate 1 gene in one Chinese family with ankylosing spondylitisJu Rong, Qiuxia Li, Pingping Zhang, et al.
International Journal of Rheumatic Diseases|August 18, 2012
Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitisZaiying Hu, Manlong Xu, Qiuxia Li, et al.
Frontiers in Pharmacology|March 27, 2020
Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative StudyJialing Wu, Xinyu Wu, Zena Chen, et al.
Arthritis Research & Therapy|June 21, 2020
TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitisMingcan Yang, Qing Lv, Qiujing Wei, et al.
Clinical and Experimental Rheumatology|September 21, 2013
Limitations of lumbar spine MRI in the diagnosis of ankylosing spondylitisZaiying Hu, Manlong Xu, Zhiming Lin, et al.
Frontiers in Immunology|September 12, 2022
Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trialLiudan Tu, Minjing Zhao, Xiaohong Wang, et al.
Pageof 4